GRAND RAPIDS—Shoulder Innovations Inc., a developer of shoulder replacement devices, announced a move to a new headquarters in Grand Rapids that is six times larger than the company’s prior headquarters in Holland.
The company said it has tripled its staff so far in 2021 amid rapid growth.
The company recently received FDA clearance for its InSet Reverse Shoulder system, which seamlessly integrates and rounds out a product line for shoulder arthroplasty, as announced in a recent press release. The InSet Reverse Shoulder System significantly expands the company’s product line and is currently in its early release, with its full scale launch in the fall of this year.
“The move into the new Shoulder Innovations corporate office and distribution facility coincides with the 510k clearance of the InSet Reverse Shoulder System; both of which are major milestones and inflection points for the business,” said Matt Ahearn, the company’s COO. “This new facility provides the space and systems for the Shoulder Innovations team to efficiently and effectively serve our surgeon and commercial partners, and it has the capacity to support our growth for the next decade.”
Added Doug Hynek, the company’s distribution and customer service director: “The correct strategic location for a distribution facility is critical for serving our commercial team and surgeon customers. Space that allows for optimal operational flow and efficiency is equally important. Our new headquarters achieves both goals. With our new corporate facility and distribution center minutes from downtown and in close proximity to the airport, we are well positioned to service last minute requests from our customers. This location enables us to attract top talent and to have everything necessary to service our national customer base.”
Leveraging its breakthrough, patented, InSet Glenoid design, Shoulder Innovations is commercializing a shoulder replacement implant system focused on improving outcomes related to the greatest cause of shoulder replacement failure: glenoid loosening. The InSet technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplifies surgical the surgical technique, potentially reducing complications or increase implant longevity.
More at shoulderinnovations.com.